Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASCENDIS PHARMA A/S

(ASND)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
125.39 USD   +2.99%
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/22Ascendis Pharma to Participate in the 5th Annual Evercore ISI HealthCONx Conference
AQ
11/16European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
ETFs positioned on ASCENDIS PHARMA A/SETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
ALPS Medical Breakthroughs ETF - USD2.97%4.65%United_States
Virtus LifeSci Biotech Products ETF - USD1.91%7.03%United_States
Global X Guru Index ETF - USD1.61%3.38%United_States
Mackenzie Maximum Diversification Developed...1.05%2.09%Europe
Mackenzie Maximum Diversification All World...0.65%2.95%World
Invesco Nasdaq Biotechnology ETF - USD0.6%4.13%-United_States
IShares Nasdaq US Biotechnology (D) - USD0.59%2.61%United_States
IShares Nasdaq US Biotechnology - USD0.59%2.66%United_States
IShares Biotechnology ETF - USD0.45%3.44%-NC
Mackenzie Maximum Diversification All World...0.12%1.98%-World
Fidelity NASDAQ Composite Index ETF - USD0.03%2.06%-United_States



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart ASCENDIS PHARMA A/S
Duration : Period :
Ascendis Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 119,58 €
Average target price 154,17 €
Spread / Average Target 28,9%
Chart ASCENDIS PHARMA A/S
Duration : Period :
Ascendis Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
ASCENDIS PHARMA A/S-6.79%7 006
VERTEX PHARMACEUTICALS46.34%82 493
REGENERON PHARMACEUTICALS, INC.21.36%81 852
BIONTECH SE-34.16%41 250
WUXI APPTEC CO., LTD.-34.47%32 173
GENMAB A/S24.60%30 178